Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4442069
Max Phase: Preclinical
Molecular Formula: C33H48F4N2O4S
Molecular Weight: 644.82
Molecule Type: Unknown
Associated Items:
ID: ALA4442069
Max Phase: Preclinical
Molecular Formula: C33H48F4N2O4S
Molecular Weight: 644.82
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1CN(S(=O)(=O)c2ccccc2C(F)(F)F)C(C)CN1C[C@@]1(O)CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](O)[C@H](F)C[C@@H]32)C1
Standard InChI: InChI=1S/C33H48F4N2O4S/c1-20-18-39(44(42,43)28-8-6-5-7-25(28)33(35,36)37)21(2)17-38(20)19-32(41)14-13-30(3)22(16-32)9-10-23-24(30)11-12-31(4)26(23)15-27(34)29(31)40/h5-8,20-24,26-27,29,40-41H,9-19H2,1-4H3/t20?,21?,22-,23+,24-,26-,27+,29-,30-,31-,32+/m0/s1
Standard InChI Key: LQISPUJFABDDLJ-LTVVLKPRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 644.82 | Molecular Weight (Monoisotopic): 644.3271 | AlogP: 5.87 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.08 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.43 | CX Basic pKa: 7.37 | CX LogP: 5.36 | CX LogD: 5.07 |
Aromatic Rings: 1 | Heavy Atoms: 44 | QED Weighted: 0.40 | Np Likeness Score: 0.46 |
1. Cortés-Benítez F, Roy J, Perreault M, Maltais R, Poirier D.. (2019) A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships., 62 (15): [PMID:31268309] [10.1021/acs.jmedchem.9b00624] |
Source(1):